![Vito Palombella](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vito Palombella
Directeur/Membre du Conseil chez MOLECULAR PARTNERS AG
Profil
Vito J Palombella currently works at Molecular Partners, Inc., as Director, Molecular Partners AG, as Independent Director from 2020, Atlas Venture Advisors, Inc., as Advisor, and TRIANA Biomedicines, Inc., as Chief Scientific Officer from 2023.
Dr. Palombella also formerly worked at Millennium Pharmaceuticals, Inc., as Senior Director-Cell & Molecular Biology from 1999 to 2000, LeukoSite, Inc., as Senior Director-Cell & Molecular Biology, Bioverativ Therapeutics, Inc., as Director-Molecular Biology & Protein Chemistry from 2000 to 2004, Infinity Pharmaceuticals, Inc., as Chief Scientific Officer & Executive VP from 2015 to 2016, and Surface Oncology, Inc., as Chief Scientific Officer from 2016 to 2023.
Dr. Palombella received his undergraduate degree from Rutgers State University of New Jersey and graduate degree and doctorate degree from New York University.
Postes actifs de Vito Palombella
Sociétés | Poste | Début |
---|---|---|
MOLECULAR PARTNERS AG | Directeur/Membre du Conseil | 01/04/2020 |
Molecular Partners, Inc.
![]() Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Directeur/Membre du Conseil | - |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
Santi Therapeutics, Inc.
![]() Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Santi Therapeutics, Inc. provides pharmaceutical services. The company is headquartered in Boston, MA. | Corporate Officer/Principal | 01/09/2023 |
Anciens postes connus de Vito Palombella
Sociétés | Poste | Fin |
---|---|---|
SURFACE ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 08/09/2023 |
INFINITY PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 22/01/2016 |
Bioverativ Therapeutics, Inc.
![]() Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2004 |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/10/2000 |
LeukoSite, Inc.
![]() LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Corporate Officer/Principal | 01/01/1999 |
Formation de Vito Palombella
Rutgers State University of New Jersey | Undergraduate Degree |
New York University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
MOLECULAR PARTNERS AG | Health Technology |
Entreprise privées | 7 |
---|---|
Bioverativ Therapeutics, Inc.
![]() Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
![]() LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
Surface Oncology, Inc.
![]() Surface Oncology, Inc. BiotechnologyHealth Technology Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). Its pipeline also includes licensed product programs, such as a collaboration with Novartis targeting CD73 (NZV930, Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813, preclinical). The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Molecular Partners, Inc.
![]() Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Santi Therapeutics, Inc.
![]() Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Santi Therapeutics, Inc. provides pharmaceutical services. The company is headquartered in Boston, MA. | Health Technology |